Anna Partyka

Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT1A/5-HT2A/5-HT7 and dopamine D2/D3 receptors

Paweł Zajdel, Krzysztof Marciniec, Andrzej Maślankiewicz et al. · European Journal of Medicinal Chemistry · 2012 · 110 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Novel 1<i>H</i>-Pyrrolo[3,2-<i>c</i>]quinoline Based 5-HT₆ Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with Alzheimer’s Disease

Katarzyna Grychowska, Grzegorz Satała, Tomasz Kos et al. · ACS Chemical Neuroscience · 2016 · 84 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor—5-HT1A/5-HT2A/5-HT7 and D2/D3/D4—agents: The synthesis and pharmacological evaluation

Paweł Zajdel, Krzysztof Marciniec, Andrzej Maślankiewicz et al. · Bioorganic & Medicinal Chemistry · 2012 · 69 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Antidepressant‐like activity of CGP 36742 and CGP 51176, selective GABA_B receptor antagonists, in rodents

Gabriel Nowak, Anna Partyka, Bernadeta Szewczyk et al. · British Journal of Pharmacology · 2006 · 69 citations · Full text

Medicine, Neuroscience, Pharmacology +17

The 1,3,5-Triazine Derivatives as Innovative Chemical Family of 5-HT6 Serotonin Receptor Agents with Therapeutic Perspectives for Cognitive Impairment

Gniewomir Latacz, Annamaria Lubelska, Magdalena Jastrzębska‐Więsek et al. · International Journal of Molecular Sciences · 2019 · 54 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15